Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $9.7 Million Registered Direct Offering

Press Release – New York, NY – April 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, in approximately $9.7 million registered direct offering of 986,000 shares of its common stock and warrants to purchase up to an aggregate of 986,000 shares of its common stock. Maxim Group LLC acted as the sole placement agent for the offering

The Sichenzia Ross Ference Carmel LLP team was led by partners Marc J. Ross, Thomas Rose, David Manno, Matt Siracusa and law clerk Soumya Cheedi.